Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) EBT Margin (2016 - 2026)

Usana Health Sciences (USNA) has disclosed EBT Margin for 15 consecutive years, with 0.84% as the latest value for Q3 2025.

  • On a quarterly basis, EBT Margin fell 845.0% to 0.84% in Q3 2025 year-over-year; TTM through Sep 2025 was 5.24%, a 550.0% decrease, with the full-year FY2024 number at 8.94%, down 219.0% from a year prior.
  • EBT Margin was 0.84% for Q3 2025 at Usana Health Sciences, down from 7.98% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 14.71% in Q4 2021 to a low of 339437.5% in Q3 2021.
  • A 5-year average of 21723.9% and a median of 10.0% in 2022 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: crashed -33945294bps in 2021, then soared 33944858bps in 2022.
  • Usana Health Sciences' EBT Margin stood at 14.71% in 2021, then tumbled by -32bps to 10.0% in 2022, then rose by 20bps to 12.04% in 2023, then tumbled by -59bps to 4.88% in 2024, then crashed by -83bps to 0.84% in 2025.
  • Per Business Quant, the three most recent readings for USNA's EBT Margin are 0.84% (Q3 2025), 7.98% (Q2 2025), and 6.71% (Q1 2025).